Aflunov®: a prepandemic influenza vaccine

A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly

(2010) E. Fragapane et al.   Clinical and Vaccine Immunology

Surveillance for Influenza during the 2009 Influenza A (H1N1) Pandemic-United States, April 2009-March 2010

(2010) L. Brammer et al.   CLINICAL INFECTIOUS DISEASES

2009 Pandemic Influenza A (H1N1) Deaths among Children—United States, 2009–2010

(2010) Chad M. Cox et al.   CLINICAL INFECTIOUS DISEASES

Neurological complications of pandemic influenza (H1N1) in children

(2010) Dinçer Yıldızdaş et al.   EUROPEAN JOURNAL OF PEDIATRICS

Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence

(2010) T. Vesikari et al.   PEDIATRICS

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I–II randomized trial

(2010) Jiang Wu et al.   VACCINE

The Signature Features of Influenza Pandemics — Implications for Policy

(2009) Mark A. Miller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults

(2009) Angelika Banzhoff et al.   PLoS One

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

(2009) G. Galli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults

(2009) Isabel Leroux-Roels et al.   VACCINE

Influenza pandemics: a historical retrospect

(2009) Eugenia Tognotti   Journal of Infection in Developing Countries

Antibody Persistence after 2‐Dose Priming and Booster Response to a Third Dose of an Inactivated, Adjuvanted, Whole‐Virion H5N1 Vaccine

(2008) Jiang‐Tao Lin et al.   JOURNAL OF INFECTIOUS DISEASES

Human infection with highly pathogenic H5N1 influenza virus

(2008) Andrea Gambotto et al.   LANCET

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

(2008) Jens Wrammert et al.   NATURE

Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1

(2008) Iain Stephenson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

(2008) Terry M. Nolan et al.   VACCINE

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

(2008) Terry Nolan et al.   VACCINE

Safety of MF59™ adjuvant

(2008) Viola Schultze et al.   VACCINE